Hyperglycemia and nocturnal systolic blood pressure are associatedwith left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients
Tóm tắt
The aim of this study was to determine if hypertensive type 2 diabetic patients, when compared to patients with essential hypertension have an increased left ventricular mass index (LVMI) and a worse diastolic function, and if this fact would be related to 24-h pressoric levels changes. Ninety-one hypertensive patients with type 2 diabetes mellitus (DM) (group-1 [G1]), 59 essential hypertensive patients (group-2 [G2]) and 26 healthy controls (group-3 [G3]) were submitted to 24-h Ambulatory Blood Pressure Monitoring (ABPM) and echocardiography (ECHO) with Doppler. We calculated an average of fasting blood glucose (AFBG) values of G1 from the previous 4.2 years and a glycemic control index (GCI) (percentual of FBG above 200 mg/dl). G1 and G2 did not differ on average of diurnal systolic and diastolic BP. However, G1 presented worse diastolic function and a higher average of nocturnal systolic BP (NSBP) and LVMI (NSBP = 132 ± 18 vs 124 ± 14 mmHg; P < 0.05 and LVMI = 103 ± 27 vs 89 ± 17 g/m2; P < 0.05, respectively). In G1, LVMI correlated with NSBP (r = 0.37; P < 0.001) and GCI (r = 0.29; P < 0.05) while NSBP correlated with GCI (r = 0.27; P < 0.05) and AFBG (r = 0.30; P < 0.01). When G1 was divided in tertiles according to NSBP, the subgroup with NSBP≥140 mmHg showed a higher risk of LVH. Diabetics with NSBP≥140 mmHg and AFBG>165 mg/dl showed an additional risk of LVH (P < 0.05; odds ratio = 11). In multivariate regression, both GCI and NSBP were independent predictors of LVMI in G1. This study suggests that hyperglycemia and higher NSBP levels should be responsible for an increased prevalence of LVH in hypertensive patients with Type 2 DM.
Tài liệu tham khảo
Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A: New type of cardiomyopathy associated with diabetic glomeruloesclerosis. Am J Cardiol. 1972, 30: 595-602. 10.1016/0002-9149(72)90595-4.
Blumenthal HT, Alex M, Goldenberg S: A study of lesions of the intramural coronary artery branches in diabetes mellitus. Arch Pathol. 1960, 70: 13-28.
Fein FS: Diabetic cardiomyopathy. Diabetes Care. 1990, 13: 1169-1179.
Barbagallo M, Gupta R, Resnick L: Cellular ions in NIDDM: relation of calcium to hyperglycemia and cardiac mass. Diabetes Care. 1996, 19: 1393-1398.
Paulson DJ, Crass MF: Myocardial triacyglycerol fatty acid composition in diabetes mellitus. Life Sci. 1980, 27: 2237-2243. 10.1016/0024-3205(80)90390-2.
Uusitupa M, Mustonen J, Airaksinen J: Diabetic heart muscle disease. Ann Med. 1990, 22: 377-386.
Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T: Left ventricular mass in diabetes-hypertension. Arch Int Med. 1992, 152: 1001-1004. 10.1001/archinte.152.5.1001.
Vicenza S, Menzinger G: Relationship between autonomic neuropahty, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care. 1994, 17: 578-584.
Felício JS, Ferreira SRG, Plavnik FL, Moisés V, Kohlmann O, Ribeiro AB, Zanella MT: Effect of blood glucose on left ventricular mass in patients with hypertension and type 2 diabetes mellitus. Am J Hypertens. 2000, 13 (11): 1149-1154. 10.1016/S0895-7061(00)01200-0.
Joint National Committe on Detection, Evaluation and Treatment of High Blood Pressure: The Fifth Report of The Joint National Committe on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993, 153: 154-10.1001/archinte.153.2.154.
National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979, 28: 1039-1057.
Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantification in M-mode echocardiography measurements. Circulation. 1978, 58: 1072-1083.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986, 57: 450-458. 10.1016/0002-9149(86)90771-X.
Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987, 59: 956-960. 10.1016/0002-9149(87)91133-7.
Nishimura RA, Abel MD, Hatle LK, Tajek AL: Assessment of diastolic function of the heart: background and current aplications of Doppler echocardiography. Part II. Clinical studies. Mayo Clin Proc. 1989, 64: 181-204.
Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977, 55: 613-618.
Palmieri V, Bella JN, Arnett DK, Liu JE, Obverman A, Schuck MY, Kitzman DW, Hopkins PN, Morgan D, Rao DC, Devereux RB: Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001, 103: 102-107.
Tenenbaum A, Fisman EZ, Schwammenthal E, Adler Y, Benderly M, Motro M, Shemesh J: Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus. Cardiovasc Diabetol. 2003, 23: 14-10.1186/1475-2840-2-14.
Galderisi M, Anderson KM, Wilson PW, Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991, 68: 85-89. 10.1016/0002-9149(91)90716-X.
Nielsen F, Rossing P, Bang L, Svendsen T, Gall M, Smidt U, Parving H: On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes. 1995, 44: 783-789.
Mulec H, Blohme G, Kullenberg K, Nyberg G, Björck S: Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia. 1995, 38: 216-220.
Rutter MK, McComb JM, Fotster J, Brady S, Marshall SM: Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria. Diabetic Medicine. 2000, 17 (4): 321-10.1046/j.1464-5491.2000.00262.x.
Molnar GD, Taylor WF, Longworthy A: On measuring the adequacy of diabetes regulation: comparison of continuously monitored blood glucose patterns with values at selected time points. Diabetologia. 1974, 10: 139-143. 10.1007/BF01219670.
Holman RR, Turner RC: The basal plasma glucose. a simple relevant index of maturity-onset diabetes. Diabetes. 1980, 14: 279-286.
Aleyassine H, Gardiner J, Toules DB, Koch P: Glycosylated haemoglobin in diabetes mellitus: correlation with fasting plasma-glucose, serum lipids and glucosuria. Diabetes Care. 1980, 3: 508-514.
Graf RJ, Holger JB, Porte D: Glycosylated haemoglobin in normal subjects and in subjects with maturity onset diabetes. Evidence for a saturable system in man. Diabetes. 1978, 27: 834-839.
Walinder O, Wibell L, Tuvemo T: Relation between haemoglobin A1 and determination of glucose in diabetes treated with and without insulin. Diabete Metab. 1980, 6: 251-255.
Wettre S, Arnqvist HJ, Von Schenck H: Assessement of glycaemic control in non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest. 1993, 53: 163-170.
Andersson DKG, Svãrdsudd K: Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care. 1995, 18: 1534-1543.
Hansen KW, Pedersen MM, Marshal SM, Christiansen JS, Mogensen CE: Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia. 1992, 35: 1074-1079. 10.1007/BF02221684.
Gambardella S, Frontoni S, Spallone V: Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens. 1993, 6: 97-102.
Coutinho M, Gerstein HC, Yang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999, 22: 233-240.
Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Hoof RV, Amery AK: Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol. 1991, 1: 723-727. 10.1016/0002-9149(91)90529-T.
Levy D, Garrison RJ, Savage DD, Kannel WB, Casteli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Eng J Med. 1990, 322: 1561-1566.
Ghali KJ, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS: The prognostic role of left ventricular hypertrophy in patients with and without coronary artery disease. Ann Intern Med. 1992, 117: 831-836.
Fujita M, Mikuniva A, McKnown DP, McKnown MD, Franklin D: Regional myocardial volume alterations induced by brief repeated coronary oclusions in conscious dogs. J Am Coll Cardiol. 1988, 12: 1048-1053.
Naka M, Hiramatsu Q, Aizawa T, Momose A, Yoshizawa K, Shigematsu S: Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J. 1992, 123: 46-53. 10.1016/0002-8703(92)90745-H.
Koistinen MJ: Prevalence of asymptomatic myocardial ischuemia in diabetic subjects. Br Med J. 1990, 301: 92-95.
Cruickshank JM, Lewis J, Moore V, Dood C: Reversibility of left ventricular hypertrophy by differing types of antihypertensive teraphy. J Hum Hypertens. 1992, 6: 85-90.
Salmasi AM, Rawlins S, Dancy M: Left ventricular hypertrophy and preclinical impaired glucose tolerance and diabetes mellitus contribute to abnormal left ventricular diastolic function in hypertensive patients. Blood Press Monit. 2005, 10 (5): 231-238. 10.1097/01.mbp.0000172710.82287.36.
Westo RS, Zarich SW, Jacob RM, Kamalesh M: From Heart disease in diabetes. Joslin's diabetes mellitus – 13th. Philadelphia. 1994, 836-851.
Aepfelbacher FC, Yeon SB, Weinrauch LA, D'Elia J, Burger AJ: Improved glycemic control induces regression of left ventricular mass in patients with type 1 diabetes mellitus. Int J Cardiol. 2004, 94: 47-51. 10.1016/j.ijcard.2003.04.012.
Cuspidi C, Lonati L, Sampieri L, Michev I, Macca G, Roccanova JI, Salerno M, Fusi V, Leonetti G, Zanchetti A: Prevelence of target organ damager in treated hypertensive patients : different impact of clinic and ambulatory blood pressure control. J Hypertens. 2000, 18: 803-809. 10.1097/00004872-200018060-00020.